Home › Funds › Pale Fire Capital SE › RLMD
Pale Fire Capital SE position in RLMD
RELMADA THERAPEUTICS INC · Health Care
Pale Fire Capital SE reported holding 51,650 shares of RLMD (RELMADA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$195K, representing 0.01% of its reported portfolio and ranking #47 among its reported holdings. Pale Fire Capital SE has disclosed RLMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Pale Fire Capital SE's RLMD position evolved
Pale Fire Capital SE first disclosed a stake in RLMD in Q4 2025 at 44,550 shares (US$215K). The position peaked in Q1 2026 at 31,650 shares, worth US$220K. Across 4 filings, Pale Fire Capital SE increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 51,650 shares valued at US$195K — an increase of 20,000 shares quarter over quarter.. Notable position changes include a 29% trim in Q1 2026 (shares were roughly flat over the following quarter), a 63% increase in Q3 2026 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 44.55K | $215.18K | New |
| Q1 2026 | 31.65K | $220.28K | Reduce |
| Q2 2026 | 31.65K | $219.02K | Hold |
| Q3 2026 | 51.65K | $194.72K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RLMD and 13F data
RLMD (RELMADA THERAPEUTICS INC) is a Health Care company. 71 other funds we track also report a position in RLMD — the largest reported positions include Squadron Capital Management LLC (US$50.9M), Venrock Adviser, LLC (US$47.4M), Spruce Street Capital LP (US$26.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RLMD
- Squadron Capital Management LLC 7.35M sh · $50.86M · Q2 2026
- Venrock Adviser, LLC 6.84M sh · $47.36M · Q2 2026
- Spruce Street Capital LP 6.91M sh · $26.06M · Q3 2026
- Jones Hill Capital LP 5.24M sh · $19.75M · Q3 2026
- Ikarian Capital, LLC 2.15M sh · $14.87M · Q2 2026
- STEMPOINT CAPITAL LP 1.46M sh · $10.10M · Q2 2026
- Commodore Capital LP 1.43M sh · $9.86M · Q2 2026
- Sio Capital Management, LLC 1.00M sh · $6.94M · Q2 2026
- Opaleye Management Inc. 935.00K sh · $6.47M · Q2 2026
- Boxer Capital Management, LLC 842.11K sh · $5.83M · Q2 2026
- GREAT POINT PARTNERS LLC 842.11K sh · $5.83M · Q2 2026
- AdvisorShares Investments LLC 670.86K sh · $2.53M · Q3 2026
More on Pale Fire Capital SE
FAQ
How long has Pale Fire Capital SE held RLMD?
Pale Fire Capital SE has disclosed RLMD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Pale Fire Capital SE's current position in RLMD?
As of Q3 2026, Pale Fire Capital SE holds 51.65K shares of RLMD (RELMADA THERAPEUTICS INC), valued at $194.72K, representing 0.01% of its reported portfolio and ranking #47.
Has Pale Fire Capital SE been buying or selling RLMD?
In the latest 13F filing (Q3 2026), Pale Fire Capital SE increased its position in RLMD. The position peaked in Q1 2026 at 31.65K shares.
Which other funds hold RLMD?
Other major institutional holders of RLMD include Squadron Capital Management LLC, Venrock Adviser, LLC, Spruce Street Capital LP, among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.